+Compare
IRTC
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
2.73B

IRTC iRhythm Technologies Forecast, Technical & Fundamental Analysis

a provider of monitoring and diagnostic solutions for detection of cardiac arrhythmias

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for IRTC with price predictions
08:00 PM EDT Sep 19, 2023

IRTC's Indicator enters downward trend

The Aroon Indicator for IRTC entered a downward trend on September 20, 2023. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 165 similar instances where the Aroon Indicator formed such a pattern. In of the 165 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on IRTC as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IRTC turned negative on August 18, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

IRTC moved below its 50-day moving average on August 31, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IRTC crossed bearishly below the 50-day moving average on September 05, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IRTC's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRTC advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

IRTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.210) is normal, around the industry mean (24.999). P/E Ratio (0.000) is within average values for comparable stocks, (80.409). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.287). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.981) is also within normal values, averaging (59.144).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IRTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -7%. AVGR experienced the highest price growth at 155%, while HSCS experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 40%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 59
SMR Rating: 83
Profit Risk Rating: 88
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

IRTC is expected to report earnings to rise 2.66% to -62 cents per share on October 31

iRhythm Technologies IRTC Stock Earnings Reports
Q3'23
Est.
$-0.63
Q2'23
Beat
by $0.14
Q1'23
Missed
by $0.20
Q4'22
Beat
by $0.04
Q3'22
Beat
by $0.20
The last earnings report on August 03 showed earnings per share of -61 cents, beating the estimate of -75 cents. With 353.88K shares outstanding, the current market capitalization sits at 2.73B.
A.I. Advisor
published General Information

General Information

a provider of monitoring and diagnostic solutions for detection of cardiac arrhythmias

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
699 8th Street
Phone
+1 415 632-5700
Employees
1793
Web
https://www.irhythmtech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DGP39.20-0.40
-1.01%
DB Gold Double Long ETN
PJUL33.87-0.35
-1.02%
Innovator S&P 500 Power Buffer ETF July
ONOF28.83-0.48
-1.64%
Global X Adaptive US Risk Management ETF
EZA38.23-0.96
-2.45%
iShares MSCI South Africa ETF
FNGG67.20-3.55
-5.01%
Direxion Daily NYSE FANG+ Bull 2X Shares

IRTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRTC has been loosely correlated with NTRA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if IRTC jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRTC
1D Price
Change %
IRTC100%
-2.36%
NTRA - IRTC
46%
Loosely correlated
-3.80%
RVTY - IRTC
44%
Loosely correlated
-1.74%
TWST - IRTC
43%
Loosely correlated
-2.57%
SYK - IRTC
43%
Loosely correlated
-1.56%
TNDM - IRTC
43%
Loosely correlated
-6.72%
More

Groups containing IRTC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRTC
1D Price
Change %
IRTC100%
-2.36%
diagnostics
(undefined stocks)
67%
Closely correlated
-1.96%
challenging disorders
(undefined stocks)
54%
Loosely correlated
-1.44%
Medical Specialties
(undefined stocks)
50%
Loosely correlated
-1.24%
medical research
(undefined stocks)
49%
Loosely correlated
-1.41%
Medical Specialties
(undefined stocks)
49%
Loosely correlated
-1.24%
More